Position in AZN
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$557,010,646
-$129,682,572 QoQ
Shares Held
2,937,510
-15.6% QoQ
Ownership
0.189%
of shares outstanding
% of Portfolio
0.54%
of 13F equity value
Holder Rank
#52
of 1,459 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 48%
Shared 0%
None 52%
Common Shares in AZN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Pictet Asset Management Holding SA holds $3,393,842,702 across 13 Drug Manufacturers - General names. AZN ranks #2 (16.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
754,985 | $905,551,734 | |
| 2 | AZN |
Astrazeneca PLC
This page
|
2,937,510 | $557,010,646 | |
| 3 | JNJ |
Johnson & Johnson
|
1,853,258 | $470,671,934 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
2,511,962 | $317,361,279 | |
| 5 | AMGN |
Amgen Inc
|
872,311 | $315,881,259 | |
| 6 | ABBV |
AbbVie Inc.
|
909,328 | $228,823,297 | |
| 7 | MRK |
Merck & Co., Inc.
|
1,451,505 | $186,518,392 | |
| 8 | BIIB |
Biogen Inc.
|
851,819 | $184,044,013 |
All Filings in AZN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $557,010,646 | 2,937,510 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $686,693,218 | 3,481,864 | Shares | Sole | 2026-04-22 | |
| No filing history on record for this holder in this stock. | ||||||